Is there a generic for Sodium iodide i-123?

Yes. The FDA Orange Book lists 2 approved generic (ANDA) applications for Sodium iodide i-123, referencing the brand SODIUM IODIDE I 123. Generics rated with an "A" therapeutic-equivalence code are considered substitutable for the brand.

What is the reference-listed drug for Sodium iodide i-123?

SODIUM IODIDE I 123 (NDA 018671, CARDINAL HEALTH 418) is the reference-listed drug — the approved product a generic applicant must show its version is the same as.

What dosage forms of Sodium iodide i-123 are approved?

Sodium iodide i-123 is approved in the following dosage forms: capsule, solution.

FDA Orange Book · active-ingredient family

Sodium iodide i-123

Sodium iodide i-123 is approved as 2 brand and 2 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:SODIUM IODIDE I 123 · NDA 018671

Brand (NDA)

Generics (ANDA)

Listed patents

Exclusivity periods

Brand (NDA) products · capsule, solution

Product	Applicant	Application	TE	Approved
SODIUM IODIDE I 123RLD×3	CARDINAL HEALTH 418	NDA 018671	AA	May 27, 1982
SODIUM IODIDE I 123×3	GE HEALTHCARE	NDA 017630	—	Approved Prior to Jan 1, 1982

Generic (ANDA) products (2)

Product	Applicant	Application	TE	Approved
SODIUM IODIDE I 123	CURIUM	ANDA 071909	AA	Feb 28, 1989
SODIUM IODIDE I 123	CURIUM	ANDA 071910	AA	Feb 28, 1989

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Sodium iodide i-123 — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo